A comprehensive guide from microorganisms and infection to innate and adaptive immunity, antibodies, vaccination, antimicrobial resistance and immune-system disorders.
Microorganisms are part of every ecosystem and of the environments surrounding the human body. Many are harmless or beneficial, while some can cause infectious disease. Understanding disease therefore requires more than memorising names of microbes: it involves recognising how pathogens enter hosts, reproduce, spread, damage tissues, evade defenses and interact with the immune system. This article builds from the major groups of microorganisms to innate and adaptive immunity, antibodies, vaccination, immune disorders and the integrated biology of host–pathogen interactions.
Microorganisms are microscopic organisms or biological entities studied at the microscopic scale. Bacteria, fungi and many protists are cellular microorganisms. Viruses are different: they are acellular infectious agents that depend on host cells for replication. Not every microorganism causes disease. Many microbes live harmlessly with hosts, participate in nutrient cycles or contribute to food production and other useful processes.
A pathogen is an infectious agent capable of causing disease. Pathogens include certain bacteria, viruses, fungi, protists and parasitic organisms. Whether exposure results in disease depends on the characteristics of the agent and the host, as well as the route and circumstances of exposure.
Microbe does not mean disease. The important distinction is between an organism or infectious agent and its effect on a particular host under particular conditions.
Bacteria are prokaryotic cells. They do not have a membrane-bound nucleus, but they contain DNA in a nucleoid region and may carry additional DNA in plasmids. Their cell structures can include a plasma membrane, cell wall, ribosomes and, in some species, capsules, pili, flagella or other specialised features.
Many bacteria reproduce by binary fission, in which one cell divides to form two daughter cells. Under favourable conditions some bacterial populations can increase rapidly. However, growth is constrained by nutrient availability, temperature, pH, waste accumulation, competition and host defenses.
Bacterial diversity is enormous. Some bacteria are environmental decomposers or symbiotic organisms; others are pathogens. Their different structures and metabolic pathways help explain why antimicrobial drugs can target particular bacterial processes rather than all cellular functions indiscriminately.
Fungi are eukaryotic organisms that include yeasts and filamentous forms. Some fungi are important decomposers or food organisms, while others cause infections. Fungal cells have structures that differ substantially from human cells, but they are still eukaryotic, which influences both their biology and the challenge of finding selective treatments.
Protists are a diverse collection of eukaryotic organisms. Some are free-living, while certain species cause diseases in humans and other hosts. Examples of disease-causing protists include the organisms responsible for malaria and some intestinal infections.
Other infectious organisms include parasitic worms and ectoparasites. These are biologically distinct from bacteria and viruses, so their life cycles, transmission routes and control measures also differ.
Viruses contain genetic material surrounded by a protein-containing structure called a capsid; some also have a lipid envelope derived from host-cell membranes. A virus does not carry out the complete set of metabolic processes required for independent cellular life. Instead, it enters susceptible host cells and uses host resources to produce viral components.
A simplified productive infection can be described as attachment → entry → uncoating → genome replication and gene expression → assembly → release. The exact sequence and mechanisms vary between viruses. Viral disease can result from direct damage to infected cells, disruption of tissue function and the host's immune response.
Viruses are not simply "very small bacteria." They differ fundamentally in structure, replication and dependence on host cells. This is one reason antibacterial drugs do not automatically work against viral infections.
Transmission describes how an infectious agent moves from a source or reservoir to a new host. Routes can include direct contact, respiratory droplets or aerosols, contaminated food or water, contaminated objects, blood or other body fluids, and biological vectors such as mosquitoes or ticks. The importance of each route depends on the pathogen and the disease.
The chain of infection is a useful framework: infectious agent, reservoir, portal of exit, mode of transmission, portal of entry and susceptible host. Breaking one or more links can reduce the probability of transmission. Hand hygiene, ventilation, safe food and water practices, isolation when appropriate, vaccination and vector control are examples of measures that can interrupt particular links.
Colonisation means that microorganisms are present and growing on or in a host without necessarily causing disease. An infection occurs when an infectious agent enters a host and establishes itself or multiplies. Disease refers to a state in which normal structure or function is disrupted and clinical or biological effects occur.
These terms are therefore not interchangeable. A person can carry a microorganism without experiencing disease, and some infections can be asymptomatic. Disease severity can depend on pathogen virulence, infectious dose, route of entry, tissue tropism, host immune status and other host factors.
The body does not wait for a pathogen to establish an infection before defending itself. Barrier defenses include intact skin, mucous membranes, mucus, cilia, tears, antimicrobial substances and the acidic environment of the stomach. Normal microbial communities can also compete with invading organisms for space and resources.
These defenses are part of innate protection and operate continuously. If microorganisms cross these barriers, the innate immune system can respond through recognition, inflammation, phagocytosis, antimicrobial molecules and other mechanisms.
Innate immunity is present from the beginning of life and responds rapidly to many types of threats. It does not rely on the highly specific antigen recognition and long-term memory characteristic of adaptive immunity.
Cells such as neutrophils and macrophages can engulf pathogens by phagocytosis. Dendritic cells help connect innate recognition with adaptive immune activation. Natural killer (NK) cells can kill certain infected or abnormal cells. Complement proteins can help mark pathogens, recruit immune activity and damage susceptible microbial membranes.
Innate immune cells detect molecular patterns associated with pathogens using pattern-recognition receptors. Recognition can trigger cytokine signaling and inflammation. The response is powerful but must be regulated so that defense does not produce unnecessary tissue damage.
Inflammation is a coordinated response to infection or tissue injury. Chemical signals can alter local blood-vessel behaviour and attract immune cells to affected tissue. Typical features include redness, heat, swelling and pain, although the precise presentation depends on the tissue and cause.
During phagocytosis, a phagocytic cell surrounds and internalises a target. The material can then be processed within intracellular compartments containing destructive enzymes and other antimicrobial mechanisms. Phagocytes can also contribute to antigen presentation, helping activate adaptive immune responses.
Inflammation is not itself a pathogen. It is a host response. Symptoms during infection can result from both microbial activity and the immune response attempting to control the infection.
Adaptive immunity develops highly specific responses to antigens. Its major cellular components are B lymphocytes and T lymphocytes. During an immune response, lymphocytes with receptors that recognise relevant antigenic structures can become activated, proliferate and differentiate.
Helper T cells coordinate aspects of immune responses by releasing signaling molecules and interacting with other immune cells. Cytotoxic T cells can kill infected or abnormal cells when appropriately activated. B cells can differentiate into plasma cells that secrete antibodies. Some activated lymphocytes become memory cells, contributing to faster responses after later exposure to the same or a related antigen.
The adaptive response is therefore both specific and capable of memory, two properties that distinguish it from the broad rapid responses of innate immunity.
An antigen is a molecule or molecular structure that can be specifically recognised by components of the adaptive immune system. An antibody is a protein produced by plasma cells that binds a particular antigenic structure. Binding can neutralise a target, block interactions with host cells, promote aggregation or enhance removal by other immune mechanisms.
Antibodies are highly specific because their variable regions have shapes and chemical properties complementary to particular antigenic sites. Different antibody classes have different distributions and functions, but all antibodies are part of the broader adaptive immune system.
Vaccination is an immunological strategy designed to prepare the immune system to respond to a pathogen or pathogen component without requiring the person to experience the full disease. Vaccine technologies differ, but the intended biological principle is to generate protective immune memory and, where possible, reduce disease severity and transmission.
After an initial antigen exposure, the immune response takes time to develop. Memory B and T cells can persist after the response contracts. A later exposure can therefore produce a faster and stronger response. The degree of protection varies by pathogen, vaccine, individual and time since vaccination.
Vaccination does not mean that every vaccinated person can never become infected. Population-level protection also depends on how effectively a vaccine prevents infection or transmission, how long protection lasts and how widely protection is distributed.
Antimicrobial treatment targets microorganisms or infectious agents. Antibiotics are medicines directed against bacteria or bacterial processes; they do not directly eliminate viruses. Antifungal drugs target fungi, while antiparasitic medicines target particular parasites. Treatment selection therefore depends on identifying or strongly suspecting the type of infectious agent.
Antimicrobial resistance occurs when microorganisms evolve or acquire traits that reduce the effectiveness of medicines against them. Selection pressure can favour resistant variants when susceptible microorganisms are inhibited or killed. Resistance can spread through reproduction and, especially among bacteria, through exchange of genetic material.
Responsible antimicrobial use, infection prevention, surveillance and development of effective treatments are important components of reducing the impact of resistance. The basic evolutionary principle is straightforward: when an antimicrobial creates a survival advantage for resistant organisms, resistance can become more common in the population.
An effective immune system must balance protection with control. Immunodeficiency occurs when immune defenses are absent, insufficient or delayed, increasing susceptibility to particular infections. Immunodeficiencies can be inherited or acquired and can affect different components of immunity.
At the other extreme, immune responses can become inappropriate or excessive. Hypersensitivity refers to harmful immune responses to otherwise harmless substances or antigens. Autoimmunity occurs when immune responses are directed against the body's own components because normal immune tolerance has failed. These disorders can involve complex interactions between genetic susceptibility and environmental factors.
The immune system can also contribute to tissue injury during infection. Thus, successful host defense is not simply "more immunity"; it is an appropriately targeted and regulated response.
Infection can be understood as a dynamic interaction rather than a one-way attack. A pathogen has biological traits that influence entry, replication, transmission and immune evasion. The host has physical barriers, innate defenses and adaptive responses. The outcome depends on their interaction over time.
Pathogens can evolve mechanisms that interfere with immune detection or destruction, while hosts evolve defenses that counter them. This creates an ongoing biological interaction shaped by evolution.
For an unfamiliar infectious-disease question, identify four things first: the agent, the route, the host response and the outcome. Then ask which link in the chain of infection or which level of immunity is being affected.
The explanatory text and diagrams in this EDUSAMBAM article are newly written and newly drawn. The following open educational resources were used for factual cross-checking and further study rather than reproduced as article content.
Copyright note: This article uses original EDUSAMBAM educational wording and original diagrams. External sources are linked for factual verification and further reading; no long source passages or source figures are reproduced here.
15 questions. Select an answer for each, then submit to see your score instantly.